People
Maitland has made four senior appointments within its Guernsey Fund Administration division, as it continues to service its growing Guernsey client base.
Harry Rouillard has been appointed Director, whilst Luke Smith, Aimée Gontier, and James Taylor have been appointed as Assistant Mangers.
Guernsey Managing Director, Wikus van Schalkwyk, says: “Now in our fifth year of operation, our Fund Administration business has gone from strength-to-strength via continued robust organic growth. Cultivating our own talent is integral to Maitland’s growth strategy, and we are delighted to have been able to promote staff internally into new roles created to support this.”
Dr Louise Rix, a former VC at Forward Partners, is stepping into the start-up world and taking up a new role as Chief Medical Officer at femtech start-up Béa Fertility.
Co-founded by femtech expert Tess Cosad, embryologist David O’Rourke and product engineer George Thomas, Béa Fertility is developing clinical-grade, at-home fertility treatments for people who are struggling to conceive naturally. The startup raised USD1 million in pre-seed funding earlier this year to expand their team and bring their pioneering fertility solution to market. The round was led by Calm/Storm VC and joined by Q Ventures.
As Chief Medical Officer,
Amadeus Capital Partners has expanded its deep tech investment team with the appointment of Dr Manjari Chandran-Ramesh as a Partner in its Early Stage Team.
Chandran-Ramesh will focus on investing in start-ups and spinouts centring on machine learning and quantum technologies, in the Oxford innovation cluster and other university centres throughout the UK.
Chandran-Ramesh joins with more than a decade of experience in commercialising university intellectual property (IP) and a PhD in Machine Learning and Autonomous Vehicles, completed at the University of Oxford as a Rhodes Scholar. Chandran-Ramesh has expertise in sourcing high-growth companies, helping founders to build a
ShangBay Capital, a venture capital firm focused on investing in early-stage healthcare companies, has appointed Robert Kamen PhD as a Senior Advisor.
ShangBay Capital’s team has a proven track record of identifying, financing, and building various healthcare companies over the last several years. The team brings deep operational experience from more than 100 years of combined industry experience to help entrepreneurs build lasting companies.
“Bob will bring significant value from his more than 35 years of experience of launching and operating successful biotech and pharmaceutical companies,” says William Dai, Founding Managing Partner. “His in-depth experience will help ShangBay continue to
Eight Advisory has appointed Nick Neil-Boss as Partner to lead its Transformation team in London.
Neil-Boss joins Eight Advisory UK from AlixPartners, where he was a Managing Director in their London Enterprise Improvement practice. He specialises in Value Creation pre- and post-transaction and Performance Improvement across the company lifecycle. Neil-Boss has 27 years of experience in industry and advisory. He holds an MBA from Cornell University, New York, as well as BSc and MSc. Degrees in Electrical Engineering from the University of the Witwatersrand in South Africa. He has served numerous private equity and corporate clients across a range of
European venture capital managers DN Capital has expanded its presence in the German tech ecosystem with the opening of a new office in Berlin.
Founded by venture capital industry veterans Nenad Marovac and Steve Schlenker in 2000 the Venture Capital firm has been one of the most active investors in the DACH region over the last two decades. DN Capital has been amongst the leading early investors in outstanding German tech successes like Auto1, GoStudent, HomeToGo, MisterSpex and Quandoo. This year the firm took three of its German portfolio companies public on the Frankfurt stock exchange (Auto1, Mister Spex, and
Bridges Fund Management (Bridges), a sustainable and impact investor, has appointed Eva Sarma as an Investment Director for Bridges Evergreen, its long-term capital vehicle.
Sarma previously spent 11 years at 3i, latterly as a Director in the UK private equity team. More recently she was Chief Operating Officer and Company Secretary of Level 20, a not-for-profit organisation that champions gender diversity in the private equity industry. She has extensive experience as a Non-Executive Director: she currently holds board positions with Level 20 and The Place, the UK’s premier contemporary dance centre, while her previous board positions include Mayborn, owner of
Trilantic North America, a growth-focused private equity firm, has promoted Ted Rosenwasser to Partner, bringing the firm’s leadership team to 15 Partners.
This follows the appointments of Giulianna Ruiz and Christopher Murphy to Partner and the addition of Kristin DePlatchett as Partner and Head of Investor Relations earlier this year.
Rosenwasser joined Trilantic North America as a Senior Associate in 2014 and primarily focuses on investments in the business services and light industrials sectors. He has played an instrumental role in recent platform investments in healthcare services end-markets, including Ingenovis Health and Rarebreed Veterinary Partners, that build on Trilantic
JC Flowers & Co LLC (JC Flowers or the Firm), a private investment firm dedicated to investing globally in the financial services industry, have named Tim Hanford and Eric co-Presidents of the Firm effective immediately.
Hanford, based in London, and Rahe, based in New York, are both currently Managing Directors at the Firm. JC Flowers founder Chris Flowers will continue as CEO and Chairman.
“Both Tim and Eric have been major contributors to the Firm’s success, and I look forward to continuing to work closely with them in the future,” says Flowers. “Both Eric and Tim have strong business acumen
Kieron Launder, former Chief Investment Officer at Schroders & Co, the private banking arm of the global investment manager, has joined private equity firm Growthdeck, taking up a position on its advisory board.
Launder brings with him 25 years of investment industry experience, having worked across a number of leading financial institutions, including Lazard and 15 years at Citibank. He later headed up the strategic investment advisory service at Rothschild private bank.
Launder will use his expertise and experience in wealth management to help Growthdeck continue the expansion of its high net worth investor client base.
Growthdeck is a pioneer
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
